These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11256023)

  • 61. Phase II trial of irinotecan (CPT-11) in relapsed or refractory non-Hodgkin's lymphomas.
    Ribrag V; Koscielny S; Vantelon JM; Fermé C; Rideller K; Carde P; Bourhis JH; Munck JN
    Leuk Lymphoma; 2003 Sep; 44(9):1529-33. PubMed ID: 14565655
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial.
    Dantas AA; Manhani AR; Coutinho F; Del Giglio A
    Acta Haematol; 2006; 116(4):275-8. PubMed ID: 17119330
    [No Abstract]   [Full Text] [Related]  

  • 63. Weekly chemotherapy using PMitCEBO in the palliation of recurrent non-Hodgkin's lymphoma.
    Hoskin PJ
    Acta Oncol; 1997; 36(6):573-6. PubMed ID: 9408146
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas.
    Fenchel K; Bergmann L; Wijermans P; Engert A; Pralle H; Mitrou PS; Diehl V; Hoelzer D
    Leuk Lymphoma; 1995 Aug; 18(5-6):485-92. PubMed ID: 8528057
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival.
    Aviles A; Duque G; Talavera A; Guzman R
    Leuk Lymphoma; 1996 Feb; 20(5-6):495-9. PubMed ID: 8833409
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
    Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).
    Freund M; Wunsch-Zeddies S; Schäfers M; Wysk J; Seidel I; Hiddemann W; Hanauske AR; Link H; Schmoll HJ; Poliwoda H
    Ann Hematol; 1992 Feb; 64(2):83-7. PubMed ID: 1554799
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, and bleomycin.
    Comella P; Abate G; Di Finizio G; Daponte A; Zarrilli D
    Cancer Chemother Pharmacol; 1990; 26(4):306-9. PubMed ID: 1695128
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
    Kollmannsberger C; Gerl A; Schleucher N; Beyer J; Kuczyk M; Rick O; Casper J; Sosada M; Rie C; Kanz L; Bokemeyer C
    Anticancer Drugs; 2000 Aug; 11(7):535-9. PubMed ID: 11036955
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphoma.
    Engert A; Schnell R; Küpper F; Reiser M; Engelhard M; Wilhelm M; Lathan B; Baltes-Engler S; Winterhalter B; Scheulen ME; Dederichs B; Tesch H; Wörmann B; Diehl V
    Leuk Lymphoma; 1997 Feb; 24(5-6):513-22. PubMed ID: 9086441
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma.
    Suzuki M; Tsunoda S; Koyama D; Ikeda S; Sukegawa M; Hojo H; Ohta M
    J Clin Exp Hematop; 2021 Mar; 61(1):22-28. PubMed ID: 33551437
    [TBL] [Abstract][Full Text] [Related]  

  • 72. alpha Interferon maintenance therapy in patients with low-grade non-Hodgkin's lymphomas after cytoreductive chemotherapy with prednimustine and mitoxantrone.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; Herrmann R; van de Loo J
    Eur J Cancer; 1991; 27 Suppl 4():S37-9. PubMed ID: 1799474
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
    Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
    [TBL] [Abstract][Full Text] [Related]  

  • 74. OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
    Colombi M; Guffanti A; Alietti A; Latargia ML; Vener C; Maiolo AT; Baldini L
    Leuk Lymphoma; 2000 Dec; 40(1-2):87-94. PubMed ID: 11426632
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas.
    Heider A; Niederle N
    Anticancer Drugs; 2001 Oct; 12(9):725-9. PubMed ID: 11593053
    [TBL] [Abstract][Full Text] [Related]  

  • 76. VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma.
    El Helw LM; Lorigan PC; Robinson MH; Coleman RE; Hancock BW
    Int J Oncol; 2000 Apr; 16(4):777-82. PubMed ID: 10717248
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect.
    Malipatil B; Ganesan P; Sundersingh S; Sagar TG
    Hematol Oncol Stem Cell Ther; 2011; 4(4):157-60. PubMed ID: 22198186
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phase 2 study of mitozantrone in combination with chlorambucil and prednisolone for relapsed and refractory non-Hodgkins lymphoma.
    Jones L; Cotter FE; Lord D; Newland AC
    Hematol Oncol; 1990; 8(1):41-5. PubMed ID: 2298419
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ifosfamide plus mitoxantrone as salvage treatment in non-Hodgkin's lymphomas.
    Lorusso V; Paradiso A; Guida M; Berardi F; De Lena M
    Am J Clin Oncol; 1991 Dec; 14(6):492-5. PubMed ID: 1957837
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
    Pan J; Ghimire S; Alpdogan SO; Chapman A; Carabasi M; DiMeglio M; Gong J; Martinez-Outschoorn U; Rose L; Ramirez M; Wagner JL; Weiss M; Flomenberg N; Pro B; Porcu P; Filicko-OHara J; Gaballa S
    Leuk Lymphoma; 2021 Mar; 62(3):590-597. PubMed ID: 33146052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.